Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer
- PMID: 33848645
- DOI: 10.1016/j.jogoh.2021.102145
Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer
Abstract
Background and objectives: Radical surgery is the standard primary treatment for patients with stage IB1 (FIGO 2009 staging) cervical cancer due to latent parametrial involvement. Recent studies suggested that less radical surgery was applicable for patients with no or low risk of parametrial involvement. In this study, we aimed to determine the incidence and possible predictive factors of parametrial involvement in patients with stage IB1 cervical cancer so as to evaluate whether less radical surgery was suitable for selected patients.
Methods: Clinical data of patients who underwent type C radical hysterectomy with pelvic lymphadenectomy and diagnosed as stage IB1 cervical cancer at Union Hospital, Wuhan, China from October 2014 to December 2017 were collected and analysed retrospectively. The incidence of parametrial involvement was calculated and the risk factors for parametrial involvement were evaluated by univariate and multivariate logistic regression.
Results: Among 282 eligible patients, 33 (11.7%) had parametrial involvement. Postmenopause, lymphovascular space invasion (LVSI), lymph node metastasis (LNM), deep stromal invasion (outer 1/3) and tumor size larger than 2 cm were statistically associated with parametrial involvement. Multivariate analysis showed that LNM (OR = 11.431; 95%CI: 3.455 - 37.821), deep stromal invasion (OR = 6.080; 95%CI: 1.814 - 20.382) and LVSI (OR = 7.147; 95%CI: 1.863-27.411) remained as independent risk factors for parametrial involvement in patients with stage IB1 cervical cancer.
Conclusions: The incidence of parametrial involvement in stage IB1 cervical cancer is non-negligible. Only LNM, LVSI and deep stromal invasion were independent predictors, which were not easy to evaluate accurately before surgery. Less radical surgery requires modified pre-treatment evaluation methods and prospective data support.
Keywords: Cervical cancer; LNM; LVSI; Parametrial involvement; Tumor size.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no competing interests.
Similar articles
-
Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.Gynecol Oncol. 2011 Sep;122(3):491-4. doi: 10.1016/j.ygyno.2011.05.038. Epub 2011 Jun 24. Gynecol Oncol. 2011. PMID: 21703671
-
A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.Gynecol Oncol. 2012 Jul;126(1):82-6. doi: 10.1016/j.ygyno.2012.04.016. Epub 2012 Apr 17. Gynecol Oncol. 2012. PMID: 22516661
-
Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?Obstet Gynecol Sci. 2018 Jan;61(1):88-94. doi: 10.5468/ogs.2018.61.1.88. Epub 2017 Dec 15. Obstet Gynecol Sci. 2018. PMID: 29372154 Free PMC article.
-
Risk of parametrial invasion in women with early stage cervical cancer: a meta-analysis.Arch Gynecol Obstet. 2018 Mar;297(3):573-580. doi: 10.1007/s00404-017-4597-0. Epub 2017 Nov 24. Arch Gynecol Obstet. 2018. PMID: 29177590 Review.
-
Conization and lymph node evaluation in low-risk cervical cancer. Is it time to avoid radical surgery? Retrospective series and literature review.Eur J Obstet Gynecol Reprod Biol. 2021 Nov;266:163-168. doi: 10.1016/j.ejogrb.2021.09.017. Epub 2021 Sep 17. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 34673464 Review.
Cited by
-
Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function.Dis Markers. 2022 Sep 14;2022:3611174. doi: 10.1155/2022/3611174. eCollection 2022. Dis Markers. 2022. Retraction in: Dis Markers. 2023 Jun 21;2023:9781835. doi: 10.1155/2023/9781835. PMID: 36157208 Free PMC article. Retracted. Clinical Trial.
-
Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study.Ann Surg Oncol. 2023 Sep;30(9):5577-5585. doi: 10.1245/s10434-023-13756-1. Epub 2023 Jun 25. Ann Surg Oncol. 2023. PMID: 37355522
-
Enhanced recovery after surgery in the perioperative period promotes recovery of cervical cancer patients undergoing transabdominal radical resection.Am J Transl Res. 2025 Jan 15;17(1):230-238. doi: 10.62347/IOZV1140. eCollection 2025. Am J Transl Res. 2025. PMID: 39959205 Free PMC article.
-
The prognostic value of radiological and pathological lymph node status in patients with cervical cancer who underwent neoadjuvant chemotherapy and followed hysterectomy.Sci Rep. 2024 Jan 24;14(1):2045. doi: 10.1038/s41598-023-49539-7. Sci Rep. 2024. PMID: 38267449 Free PMC article.
-
The predictive value of serum inflammatory markers for the severity of cervical lesions.BMC Cancer. 2024 Jun 28;24(1):780. doi: 10.1186/s12885-024-12561-7. BMC Cancer. 2024. PMID: 38943072 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical